Company ProfilePremium

Iluka Resources

Company Profile Analysis

Ticker: ILU.AX

ESOMAR 23 Corporate BadgeISO Certifications Badge
Iluka Resources - Chemicals & Materials showcase

Year Founded & Workforce

1998

909 Employees

Industry

Chemicals & Materials

Services

Rare Earth Metals
Iluka Resources logo

Iluka Resources Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Iluka Resources Overview

Iluka Resources is Australia's leading mineral sands producer and an emerging integrated rare earths refiner. For seven decades it has mined and processed heavy mineral sands to produce zircon (sand and zircon-in-concentrate) and high-grade titanium dioxide feedstocks (natural rutile, HyTi and synthetic rutile). These feed ceramics, pigment, welding, titanium metal and specialty markets worldwide. Its asset base is wholly Australian: Jacinth-Ambrosia (SA), Cataby and the SR2 kiln (WA, idled since 1 Dec 2025), the Narngulu separation plant, and the newly commissioned Balranald underground mine (NSW). Iluka is now transforming itself through the A$1.7–1.8bn Eneabba rare earths refinery, Australia's first fully integrated refinery for separated light and heavy rare earth oxides. Eneabba is backed by a A$1.65bn non-recourse Australian Government loan and is due to commission in 2027. Iluka also holds a ~20% stake in Deterra Royalties. The investment case is a cyclical cash-generating base funding a strategic, geopolitically advantaged rare earths platform.


Company's own description

Iluka describes itself as a global critical minerals company. Its expertise spans exploration, development, mining, processing, marketing and rehabilitation. It cites more than 70 years of industry experience and calls itself a leading producer of zircon and of the high-grade titanium dioxide feedstocks rutile and synthetic rutile. Iluka also states that it has established a significant position in rare earths. Its products are used in technology, construction, medical, lifestyle, defence and industrial applications. Operations and projects are in Australia, supported by a globally integrated marketing network. Exploration is conducted internationally, and Iluka manages rehabilitation of legacy operations in the United States and Australia. (Company profile text used in its website and annual report boilerplate; corroborated by data-provider business descriptions.)

The 2025 Annual Report frames the year as one of contrasting dynamics. Mineral sands faced subdued demand and disruption in the pigment industry. Rare earths, by contrast, were recognised by governments and consumers as a strategic priority, validating the diversification Iluka has pursued since 2022 (FY2025 Results release, Managing Director's commentary).

Business model

Product model (100% product sales). Iluka earns revenue almost entirely from bulk mineral product sales. There is no service, subscription or licensing revenue of note. The exceptions are:

  • its equity-accounted share of Deterra Royalties' profit (FY2025: A$30m; FY2024: A$22m);

  • minor by-product sales of ilmenite, activated carbon, gypsum and iron concentrate.

Contracting. Zircon is sold through a mix of quarterly and contract arrangements. Iluka has historically used a published Zircon Reference Price, and it sets prices quarterly in negotiation with customers. Synthetic rutile has historically been sold under multi-year take-or-pay contracts with Western chloride-pigment producers. Those contracts were renewed at the start of 2023 for four years, then rebalanced in 2025. For 2026 they cover:

  • 110kt of synthetic rutile;

  • 10kt of rutile;

  • 12kt of HyTi;

  • 100kt of ilmenite;

all with fixed or floor prices underpinning minimum contracted revenue of A$240m (Quarterly Review to 31 Dec 2025).

Rare earths model (from 2027). Iluka will sell separated rare earth oxides — NdPr, Dy, Tb and others — under offtake contracts. The first offtake (June 2026) sets price at the higher of a negotiated minimum price and a market-linked price, so that pricing is independent of China-dominated benchmarks.

Capital allocation. Iluka's dividend framework distributes a minimum share of mineral sands free cash flow not needed for investment (historically described as a minimum 40% of free cash flow). It passes through 100% of dividends received from Deterra Royalties. FY2025 Deterra dividends received were A$23m, and a A$13m Deterra dividend was received in H1 2026 for distribution.

Value chain position

Iluka is an upstream-to-midstream producer:

  1. Exploration in Australia (Eucla Basin, Perth Basin, Murray Basin) and the USA (Idaho).

  2. Mining of heavy mineral ore, by dry mining, dredging, or Iluka's proprietary remotely operated underground mining (UGM) method at Balranald.

  3. Concentration to heavy mineral concentrate (HMC).

  4. Mineral separation at Narngulu (WA). Remnant material has also been processed at North Capel and Eneabba.

  5. Upgrading of chloride ilmenite to synthetic rutile in coal-fired rotary kilns (SR2 at Capel; SR1 paused since October 2023).

  6. Rare earths refining. From 2027 Iluka will move further downstream into cracking, leaching and solvent-extraction separation to produce individual rare earth oxides at Eneabba.

Iluka does not make pigment, zirconium chemicals, ceramics, metals or magnets. Its customers do.

Customer types and end-markets

ProductPrincipal customer typesEnd-markets
Zircon sand (premium/standard)Ceramic frit/opacifier producers, zircon millers, foundries, zirconium chemical producersCeramic tiles and sanitaryware (China, Europe, India), foundry/precision casting, refractories, zirconium chemicals, nuclear, medical/dental
Zircon-in-concentrate (ZIC)Chinese processors (lower-cost feed)As above, after further processing by the customer
Rutile (95% TiO₂)Welding-electrode makers (premium), chloride pigment producers, titanium sponge/metal producersWelding, TiO₂ pigment (paints, plastics, paper), titanium metal (aerospace)
HyTi (70–90% TiO₂)Pigment producers, welding fluxPigment, welding
Synthetic rutile (~88–95% TiO₂)Western chloride pigment producers (e.g., Chemours, Tronox; Venator historically)TiO₂ pigment, closely tied to US housing and construction
Ilmenite (sulphate/chloride)Pigment producers, slaggersPigment
Rare earth oxides (from 2027/28)Automotive OEMs, magnet makers, metals and alloy producersPermanent magnets for EVs, wind turbines, defence, electronics

Independent characterisation

Iluka is in the middle of a structural transition. It is moving from a pure-play, cyclical mineral sands producer whose earnings are geared to Chinese ceramics demand and Western pigment demand, towards a hybrid. That hybrid pairs a sub-scale but strategic rare earths refiner with a mineral sands business now operating at reduced capacity.

The mineral sands business has moved from record profitability in 2022 (mineral sands EBITDA margin 53–56%) to near breakeven in H1 2026 (9% margin). The drivers are:

  • weak pigment demand and capacity closures in Europe and China;

  • Chinese competition in zircon and low-grade rutile;

  • the loss of Venator volumes;

  • the idling of Cataby and SR2.

Meanwhile, the balance sheet has moved from net cash to group net debt of A$1.15bn at 30 June 2026. That debt is predominantly non-recourse government debt (A$877m in rare earths). Value is therefore increasingly concentrated in a single, not-yet-commissioned asset (Eneabba). Its economics depend on rare earth pricing outside China, on feedstock diversification and on execution.

Strategy

Stated strategy themes (2025 Annual Report, FY2025 and H1 2026 releases)

Management's recurring framing rests on five themes:

  1. Diversification of mineral sands and rare earths as complementary businesses.

  2. Operational and market discipline — producing to demand and not chasing volume into a weak market.

  3. Capital allocation discipline, including a dividend framework with 100% pass-through of Deterra dividends.

  4. Balance sheet management.

  5. Disciplined execution of Balranald and Eneabba.

Management describes external developments as having "validated Iluka's approach." The Chair framed 2026 as a year of "laser focus" on completing Eneabba (ASA AGM report). The H1 2026 release states that 2026 is "an important year of execution."

Strategic initiatives (last 24 months)

InitiativeDetailStatus
Eneabba rare earths refineryAustralia's first fully integrated rare earths refinery (light and heavy separated oxides); capex A$1.7–1.8bn; >A$1bn spent or committed by Feb 2026; A$1,101m capex spent to 30 Jun 2026; engineering >95% complete; roaster kiln and all major equipment delivered60% constructed; commissioning 2027 (mid-2027 per June 2026 EFA release)
Government partnershipA$1.65bn non-recourse EFA loan (A$1.25bn Tranche 1 plus A$400m Tranche 2, confirmed June 2026); A$150m cost-overrun facility shared 50/50; additional A$214m Iluka equityFull facility access confirmed 23 Jun 2026
Rare earths offtakeFirst take-or-pay agreement with a global automaker, 2028–2031, with minimum price floorsExecuted 23 Jun 2026; further customers in discussion
Feedstock diversificationNorthern Minerals (Browns Range xenotime, up to 30.5kt REO); Lindian (Kangankunde monazite, 6ktpa over 15 years plus US$20m loan); VHM (Goschen, 86kt REO over 18 years plus ROFR); internal Balranald and WimmeraAgreements signed 2023–2026; Northern supply agreement subject to conditions
BalranaldA$480m (2023 real terms) FID; novel UGM technology developed over 15 years; ore grade >50% heavy mineral in the production plan; ~60ktpa rutile, ~50ktpa zircon, rare earth creditsMining from Jan 2026; both rigs operational; first final product H2 2026
Wimmera DFSFine-grained zircon and rare earths; A$30m DFS approved Feb 2023; a further ~A$25m of studies for Wimmera and rare earth mineralisation indicated on the H1 2026 callEES and DFS in progress
Typhoon (Eucla Basin)Study costs included in 2026 mineral sands capexStudy
Cost resetQ4 2024 cost review; Q4 2025 review cut ~120 roles for ~A$36m 2026 savings; idling of Cataby and SR2 to "liberate inventory and cash"Implemented
Synthetic rutile contract rebalancing2026 contracts adjusted to minimum A$240m revenue (110kt SR, 10kt rutile, 12kt HyTi, 100kt ilmenite)In effect for 2026
Rare earth metalsEvaluation of downstream metal production (noted at the 2023 FID communications)Evaluation; no FID

ESG commitments

Rehabilitation leadership (2022 Golden Gecko Award for the Flora Restorer seeding machine) and safety metrics form part of the stated strategy.

Medium-term targets and guidance

Iluka does not publish multi-year financial targets.

  • Z/R/SR production of 265kt.

  • Cash costs of A$420m, including A$140m of Balranald production costs.

  • Unit cash cost of A$1,585/t, distorted by the Balranald ramp-up.

  • Mineral sands capex of A$60m and rare earths capex of A$600m.

The Balranald investment case targets steady state from mid-2026. Eneabba's design capacity is ~3,500tpa NdPr and ~170tpa DyTb from the Eneabba stockpile alone, with more from third-party feeds.

Products & Services

Mineral Sands — zircon

Zircon Premium. High-purity zircon sand (ZrSiO₄) with low iron and titanium impurities and high brightness/whiteness.

  • Target customers: ceramic opacifier and frit makers (tiles, sanitaryware), zirconium chemical producers, precision investment casting.

  • Main sources: Jacinth-Ambrosia and Balranald (Balranald is described as rich in premium zircon).

  • Pricing: quarterly negotiated; Iluka historically published a Zircon Reference Price.

  • Weighted average zircon premium and standard price: US$1,882/t in FY2024, US$1,643/t in FY2025, US$1,502/t in Q4 2025, and US$1,546/t in Q2 2026 with further increases expected in Q3 2026 (Quarterly Review to 30 Jun 2026).

Zircon Standard. Lower-specification zircon sand with marginally higher impurities, sold for ceramics, refractories and foundry uses where whiteness is less critical. It is reported together with premium.

Zircon-in-concentrate (ZIC). A lower-grade intermediate concentrate sold mainly to Chinese processors, who finish it themselves. Production is recognised on sale.

  • FY2025 ZIC sales were a record 110.7kt, up 70%. Iluka optimised processing of remnant material through all separation facilities (Eneabba, North Capel, Narngulu) as the market sought lower-cost material.

  • 2026 guidance is 50kt.

  • The weighted average for all zircon products including ZIC was US$1,422/t in FY2025.

Wimmera zircon (development). Wimmera's fine-grained zircon flowsheet has been tested. Customer testing indicates ~40% of extracted zircon sand is suitable for ceramics, with markets identified for ~60% of all zircon extracted (Quarterly Review to 31 Dec 2025).

Mineral Sands — titanium dioxide feedstocks

Rutile (natural, ~95% TiO₂).

  • Customers: welding-electrode manufacturers (premium pricing), chloride pigment producers, titanium sponge producers.

  • Sources: Jacinth-Ambrosia and, increasingly, Balranald, whose investment case is ~60ktpa of rutile.

  • Price (excluding HyTi): US$1,694/t in FY2024, US$1,216/t in FY2025, US$1,110/t in Q4 2025. The Q4 2025 figure reflects lower-grade (92% TiO₂) sales and pigment weighting.

  • Iluka states rutile sales will be weighted to pigment customers as Balranald comes online.

HyTi. Lower-value TiO₂ product (70–90% TiO₂), reported within rutile volumes and sold to pigment and welding customers at a discount to rutile.

Synthetic rutile (SR). Upgraded ilmenite (~88–95% TiO₂) produced in coal-fired rotary kilns. SR2 has ~225ktpa capacity (Argus, Sep 2025); SR1 is a "premium swing" kiln restarted December 2022 and paused since October 2023.

  • Customers: Western chloride pigment producers under multi-year contracts.

  • Price: US$1,205/t in FY2024, US$1,112/t in FY2025, US$1,073/t in Q4 2025.

  • 2026 production guidance is nil, with SR2 idle. Contracted 2026 SR volumes (110kt) are served from inventory.

  • Iluka can restart SR2 earlier "should market conditions support a restart."

Ilmenite.

  • Chloride ilmenite from Cataby is SR2 feed.

  • Sulphate ilmenite is sold to sulphate-route pigment producers; Balranald's investment case includes up to 150ktpa sulphate ilmenite.

  • FY2025 ilmenite production was 335kt and sales 51kt.

By-products

Activated carbon (from synthetic rutile processing), gypsum and iron concentrate, sold in small volumes and reported in "ilmenite and other revenue."

Rare Earths

Separated light rare earth oxides (from 2027).

  • Products: NdPr oxide (neodymium-praseodymium), plus lanthanum, cerium and samarium/europium/gadolinium fractions where produced.

  • Eneabba's design output using the Eneabba stockpile alone is ~3,500t of NdPr per annum once ramped up (Offtake release footnote, 23 Jun 2026).

  • Target customers: magnet makers, automotive OEMs, metal/alloy producers.

Separated heavy rare earth oxides (from 2027).

  • Products: dysprosium (Dy) and terbium (Tb) oxides — the critical heavy rare earths for high-temperature magnets.

  • Design output is ~170t per annum of DyTb from the Eneabba stockpile, with heavy rare earth-rich third-party feeds to add to this (xenotime from Northern Minerals' Browns Range, Goschen concentrate from VHM).

  • Iluka positions Eneabba as one of very few facilities outside China that will, by design, produce both separated light and heavy oxides at meaningful scale (H1 2026 call commentary).

Flagship contract. Binding take-or-pay offtake with a "globally recognised automotive company" (unnamed), commencing 2028 for four years:

  • 1,200t of magnet rare earth oxides (Nd, Pr, Dy, Tb), about 10% of planned production in the period;

  • pricing at the higher of minimum and market-linked prices;

  • minimum revenue reported at US$155m over the term (Offtake release; Motley Fool, 23 Jun 2026).

Some secondary sources describe the volume as 1,200t per year. Iluka's release frames it as 1,200t over the period, equal to ~10% of planned output. The primary-source interpretation is used here.

Rare earth concentrates (historical/intermediate). Monazite-zircon concentrate from Eneabba Phases 1–2 was historically sold or stockpiled. It is now retained as refinery feed.

Mineral Sands production profile

MetricFY2024FY2025FY2026 guidance
Zircon sand production (kt)158160130
Zircon-in-concentrate production (kt)6911150
Rutile incl HyTi production (kt)587985
Synthetic rutile production (kt)2112100
Total Z/R/SR production (kt)496559265
Cash costs of production (A$ M)644589420
Unit cash cost of production (A$/t Z/R/SR)1,2981,0541,585
Restructure and idle costs (A$ M)353285
Depreciation and amortisation (A$ M)192233135
MetricFY2024FY2025
Zircon sand sales (kt)164.9157.2
ZIC sales (kt)65.0110.7
Rutile sales (kt)45.270.8
Synthetic rutile sales (kt)200.1136.2
Total Z/R/SR sales (kt)475.2474.9
Ilmenite sales (kt)121.351.2

(Source: Quarterly Review to 31 Dec 2025, 2026 Outlook. Guidance is indicative and depends on market conditions.)

H1 2026 total sales were 282.2kt versus 278.6kt in H1 2025 (RTTNews summary of 2026 Interim Report). Q2 2026 Z/R/SR production was 58kt and sales 157kt (Quarterly Review to 30 Jun 2026).

Received prices (US$/t FOB)

MetricFY2024FY2025
Zircon premium and standard (US$/t)1,8821,643
Zircon all products incl ZIC (US$/t)1,7211,422
Rutile excl HyTi (US$/t)1,6941,216
Synthetic rutile (US$/t)1,2051,112

(Source: Quarterly Review to 31 Dec 2025, Appendix 2.)

Financial Narrative

Basis. Mineral sands and NPAT figures come from Iluka results releases. Statutory total revenue, EPS, D&A and book value per share are taken from roic.ai's standardised statutory data and are labelled as aggregator-sourced. FY2021 and as-reported FY2022 include Sierra Rutile, which was demerged in August 2022. The FY2020 statutory NPAT of A$2,412m, which reflects the Deterra demerger gain, sits outside the five-year window.

Income statement

Notes:

  • Gross profit and EBIT are not presented by Iluka on a "gross profit" basis.

  • roic.ai's standardised operating margins are 36.2% (FY2021), 45.4% (FY2022), 35.9% (FY2023), 27.4% (FY2024) and 15.0% (FY2025). These imply EBIT of roughly A$564m, A$731m, A$464m, A$320m and A$152m respectively (derived). The FY2025 figure appears to exclude impairments, so treat it with caution.

  • FY2022 EPS of 138c corresponds to attributable NPAT of A$584m (aggregator) versus the A$589m in the release.

Margins and growth

Revenue CAGR FY2021–FY2025 (derived):

  • Statutory revenue: -10.2% per annum (A$1,559m to A$1,015m).

  • Reported mineral sands revenue: -10.0% per annum (A$1,486m to A$976m).

  • On a like-for-like ex-Sierra Rutile basis, FY2022–FY2025: -14.4% per annum (A$1,524m to A$976m).

The FY2022 net margin uses group NPAT including SRL against a statutory revenue line, which may be restated. Treat it as indicative.

Commentary. The five-year arc is a classic commodity cycle overlaid with portfolio change.

FY2022 was, in management's words, "an extraordinary year." Facilities ran at capacity, products were "materially sold out," prices rose across all products, and a weaker A$ helped. Mineral sands EBITDA reached A$917m (53% margin) and NPAT A$589m, funding a 45cps dividend.

From 2023 the cycle turned:

  • Persistent inflation lifted costs, and FY2023 EBITDA margin fell to 47%.

  • In 2024, zircon pricing held up, but Iluka deliberately built ~200kt of HMC inventory to minimise unit mining costs rather than sell into weak demand. Margin was 42%.

  • In 2025, weak pigment demand, pigment plant closures in Europe and China, the Venator insolvency, aggressive discounting by a zircon competitor in China, and low-quality Chinese rutile/leucoxene compressed prices. Iluka responded by idling Cataby and SR2.

The A$566m of pre-tax impairments and inventory write-downs in FY2025 turned a positive underlying result into a statutory loss of A$288m. In H1 2026 the margin collapsed to 9%. Iluka attributes this to:

  • lower realised prices;

  • Balranald ramp-up operating costs being expensed;

  • idle costs;

  • higher unit costs on lower production.

Volumes, however, rose slightly.

Balance sheet

Notes:

  • FY2022 net cash of A$489m is from Finance News Network's report of the FY2022 result. The FY2023 release cites a mineral sands net cash comparator of A$382m, which corresponds to 30 June 2023. Both figures are shown in sources; the discrepancy reflects differing period ends.

  • Derived equity = book value per share × basic weighted average shares (aggregator).

30 June 2026 position (Interim Report):

  • Mineral sands net debt A$273m.

  • Rare earths net debt A$877m.

  • Group net debt A$1,150m.

Facilities:

  • Mineral sands commercial debt facilities of A$800m, tenor to May 2029.

  • EFA non-recourse loan of A$1.65bn: Tranche 1 of A$1.25bn expected to be fully drawn by end-2026, Tranche 2 of A$400m now confirmed available. Tenor is flexible to 2038.

  • Drawn under EFA at 31 Dec 2025: A$610m including capitalised interest.

Inventory. Management cites inventory valued at more than A$1bn (FY2025 commentary). This is a major working-capital lever and was drawn down in H1 2026.

Trade receivables: A$267m at 31 December 2025.

  • total assets;

  • cash and equivalents;

  • short-term versus long-term debt split;

  • goodwill and intangibles (Iluka carries minimal goodwill; the aggregator's tangible book value per share slightly exceeds book value per share, suggesting negligible intangibles);

  • working capital.

Cash flow

Sources: FY2022 OCF of A$711m and FY2022 group free cash inflow of A$444m are from the FY2022 presentation. The ex-SRL restated FY2022 mineral sands FCF of A$422m and FY2023 mineral sands FCF of -A$69m are from the FY2023 release. FY2024–25 figures are from the FY2025 release and the Q4 2025 quarterly.

Buybacks. No on-market buybacks were identified in FY2021–FY2026. Shares issued are limited to the DRP and employee plans; for example, 72,718 DRP shares were issued on 28 Mar 2025.

Commentary. Cash generation has inverted. In 2022, operating cash flow of A$711m comfortably funded dividends. By 2025, operating cash flow of A$61m was dwarfed by capex of A$862m, split A$419m mineral sands (Balranald completion) and A$443m rare earths (Eneabba). The result was group free cash outflow of A$888m and a A$942m swing in group net debt.

H1 2026 marks a turn in the mineral sands unit. Operating cash flow of A$247m and mineral sands FCF of A$200m came from inventory drawdown, improved zircon pricing and sharply lower capex. 2026 guidance is A$60m mineral sands capex versus A$600m rare earths capex.

Ratios

  • current ratio;

  • debt/equity — approximate FY2025 gross debt is A$473m net mineral sands plus A$610m EFA drawn, giving net debt/equity of ~0.52x (derived from A$1,057m / A$2,042m);

  • interest coverage (EFA interest is capitalised during construction);

  • asset turnover;

  • cash conversion cycle.

The long cash conversion cycle is a structural feature of the business. Inventory exceeding A$1bn against FY2025 cost of goods sold of roughly A$600m implies inventory days well above 300 (derived, indicative only).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Overview

SegmentContents

Jacinth-Ambrosia / Mid West (JA/MW)

Jacinth-Ambrosia mine (SA) and associated processing at the Narngulu mineral separation plant (Geraldton, WA)

Cataby / South West (C/SW)

Cataby mine and processing of chloride ilmenite through synthetic rutile kilns 1 and 2 (Capel/North Capel, WA)

Rare Earths (RE)

Eneabba rare earths refinery under construction, Eneabba Phases 1 and 2, feasibility studies, and Iluka's interest in Northern Minerals

United States / Murray Basin (US/MB)

Rehabilitation obligations in Florida and Virginia, plus idle Australian assets (Murray Basin)

Results by Segment and Segment Margins & Growth (%)

MetricFY2021FY2022FY2023FY2024FY2025

Mineral sands revenue, as reported (AUD Mn)

1,4861,7271,2381,129976

Mineral sands revenue, ex-Sierra Rutile basis (AUD Mn)

—1,5241,2381,129976

Underlying mineral sands EBITDA, as reported (AUD Mn)

634917582477300

Underlying mineral sands EBITDA, ex-SRL (AUD Mn)

—849582477300

Mineral sands EBITDA margin, reported (%)

4353474231

Share of profit of associate, Deterra (AUD Mn)

1830—2230

Underlying group EBITDA (AUD Mn)

———499329

Rare earths capex (AUD Mn)

—16—162443

Mineral sands capex (AUD Mn)

———272419

Results by Segment and Segment Margins & Growth (%) (Half-Yearly)

MetricH1 2025H1 2026Change (%)

Mineral sands revenue (AUD Mn)

558433-22

Underlying mineral sands EBITDA (AUD Mn)

21841-81

Mineral sands EBITDA margin (%)

399-76

Share of profit of Deterra (AUD Mn)

1512-19

Underlying group EBITDA (AUD Mn)

23353-77

Group EBIT (AUD Mn)

148-10—

NPAT (AUD Mn)

92-24—

Mineral sands operating cash flow (AUD Mn)

115247115

Mineral sands free cash flow (AUD Mn)

-192200—

Group free cash flow (AUD Mn)

-371-66—

Revenue by Segment and Unit Economics (AUD/tonne)

MetricFY2024FY2025

Z/R/SR revenue (AUD Mn)

1,043908

Ilmenite and other revenue (AUD Mn)

8567

Mineral sands revenue (AUD Mn)

1,128976

Unit revenue per tonne Z/R/SR sold (A$/t)

2,1951,913

Income Statement and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Total statutory revenue, aggregator (AUD Mn)

1,5591,6111,2911,1701,015

Mineral sands revenue, as reported (AUD Mn)

1,4861,7271,2381,129976

Underlying mineral sands EBITDA (AUD Mn)

634917582477300

Underlying group EBITDA (AUD Mn)

———499329

Depreciation expense, aggregator (AUD Mn)

171144168192232

NPAT, statutory (AUD Mn)

366589343231-288

Underlying NPAT (AUD Mn)

—600343——

EPS basic (A$ cents)

871388054-67

Dividend per share, fully franked (A$ cents)

2445785

Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Mineral sands EBITDA margin (%)

4353474231

Underlying group EBITDA margin on mineral sands revenue (%)

———4434

Net margin on statutory revenue (%)

23.536.626.619.7-28.4

Mineral sands revenue YoY growth, reported (%)

—16.2-28.3-8.8-13.5

Mineral sands revenue YoY growth, ex-SRL (%)

——-18.8-8.8-13.5

Balance Sheet and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Mineral sands net cash (debt), recourse (AUD Mn)

—48930890-473

Rare earths non-recourse debt (AUD Mn)

———-205-584

Reported group net cash (debt) (AUD Mn)

———-115-1,057

Book value per share, aggregator (AUD)

3.704.455.025.504.76

Shareholders' equity, derived (AUD Mn)

1,5611,8782,1392,3492,042

Cash Flow

MetricFY2022FY2023FY2024FY2025

Operating cash flow, group (AUD Mn)

711—25261

Capital expenditure, group (AUD Mn)

——434862

Free cash flow, mineral sands (AUD Mn)

422-69-157-468

Free cash flow, group (AUD Mn)

444—-288-888

Dividends received from Deterra (AUD Mn)

———23

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2021FY2022FY2023FY2024FY2025

ROE on year-end equity, derived (%)

23.431.116.09.8-14.1

Group net debt to underlying group EBITDA, derived (x)

———0.233.21

Mineral sands net debt to mineral sands EBITDA, derived (x)

———-0.191.58

Dividend payout of statutory EPS, derived (%)

2833915—

Revenue by Region

MetricFY2023FY2024FY2025

Total mineral sands revenue (AUD Mn)

1,2381,129976

Valuation Snapshot

MetricValueSource / basis

Latest close

A$6.06 (29 Sep 2026)

InvestSMART

2026 YTD range

A$4.92 – A$8.69

InvestSMART

2025 range

A$3.14 – A$9.48

InvestSMART

2025 calendar return

+15.1% (A$5.03 to A$5.79)

InvestSMART

2026 YTD return to 29 Sep

+4.7%

InvestSMART

Australian FY2026 (Jul 2025 – Jun 2026) return

+87.5% (A$3.77 to A$7.07)

InvestSMART

~1-year return (early Oct 2025 to late Sep 2026)

Approximately -20% to -35%, depending on the October 2025 reference point given extreme volatility (2025 high A$9.48 was set during the rare earths rally)

Derived; not precise

~3-year return (Oct 2023 to Sep 2026)

Approximately -15% to -20% price only (Oct 2023 ADR ~US$23.4 implies ~A$7.3 per share)

Derived from ADR history (digrin)

~5-year return (Oct 2021 to Sep 2026)

Price-only decline of roughly -35% to -40%, but this excludes the value of the Sierra Rutile in-specie distribution (Aug 2022) and dividends.

Derived

US OTC (ILKAF)

US$3.96 (5 Oct 2026); 52-week range US$3.30–7.54; trailing EPS -US$0.64

Yahoo Finance

Capital Markets

MetricIluka

Market capitalisation (AUD Mn)

~2,610

Group net debt, 30 Jun 2026 (AUD Mn)

1,150

Enterprise value, before Deterra stake (AUD Mn)

~3,760

EV / FY2025 underlying group EBITDA (x)

~11.4

EV / FY2025 statutory revenue (x)

~3.7

P/E, trailing

Not meaningful (loss)

P/B, on FY2025 equity ~A$2,042m (x)

~1.3

Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Total dividend per share, fully franked (A$ cents)

2445785

Debt Facilities

FacilitySizeDrawn / positionMaturity

Mineral sands commercial debt facilities

A$800m

Mineral sands net debt A$273m (30 Jun 2026)

May 2029

EFA Critical Minerals Facility (non-recourse), Tranche 1

A$1,250m

Expected fully drawn end-2026

Flexible, up to 2038

EFA Tranche 2

A$400m

Available after Tranche 1 is fully drawn; condition precedent satisfied Jun 2026

Flexible, up to 2038

Cost-overrun facility

A$150m (50/50 Iluka/Government)

Contingent

—

Analyst Conclusions

Management guidance (FY2026, issued Jan 2026; reaffirmed in direction at H1)

  • Z/R/SR production of 265kt: zircon sand 130kt, ZIC 50kt, rutile 85kt, synthetic rutile nil.

  • Cash costs of production of A$420m, including A$140m for Balranald.

  • Unit cash cost of A$1,585/t.

  • Restructure and idle costs of A$85m.

  • D&A of A$135m.

  • Capex of A$60m for mineral sands and A$600m for rare earths.

  • Eneabba commissioning in 2027 (mid-2027), with capex A$1.7–1.8bn.

  • First Balranald final product in H2 2026.

  • Synthetic rutile minimum contracted revenue of A$240m for 2026.

  • Management expects to "benefit from a recovering zircon market" in H2 2026 and is prioritising operational execution and balance sheet strength.

Directionally, FY2026 is the earnings trough: H1 NPAT -A$24m, with an H2 improvement expected from zircon pricing and Balranald. FY2027 is likely to show recovery in mineral sands but carry start-up costs at Eneabba. FY2028 is the first year of offtake deliveries.

Bull case

  1. Rare earths re-rating is under way and contracted. A take-or-pay offtake with minimum prices independent of Chinese benchmarks, plus full A$1.65bn government funding and 60% construction completion, materially de-risks Eneabba. About 90% of 2028–31 output remains uncontracted, so further deals at similar floor-protected terms could underpin valuation as Western price floors proliferate.

  2. Mineral sands is past the trough. Prices described as "unsustainably low" are forcing industry rationalisation. Zircon prices rose in Q2 2026 to US$1,546/t with further increases flagged. Mineral sands net debt fell A$200m in one half, and SR2 and Cataby offer quick-restart leverage to any pigment recovery.

  3. Balranald changes the product mix. A >50% heavy mineral ore body, rich in rutile and premium zircon with rare earth credits, plus proprietary UGM technology, adds long-life, high-value production with rare earth feed for Eneabba.

Bear case

  1. Leverage and execution concentration. Group net debt of A$1.15bn and rising, an Eneabba cost history already up ~45% from FID, and a complex light-plus-heavy separation flowsheet leave equity holders exposed to any further overrun or slow ramp-up. Rare earth refinery start-ups outside China have historically disappointed on timing.

  2. Structural impairment of titanium feedstocks. Western chloride pigment capacity is shrinking (Venator), customers are loss-making, and the multi-year SR contracts renewed in 2023 roll off around 2027. SR2 may not return to its former role, and the FY2025 impairments may not be the last.

  3. Chinese price-setting power persists. Aggressive zircon discounting by competitors and record Chinese rare earth exports could keep both product suites under pressure. Uncontracted Eneabba output would then be sold at market-linked prices that undershoot Iluka's investment case.

Catalysts and monitorables (next 12 months)

  1. Q3 2026 quarterly (16 Oct 2026): zircon price realisation and Balranald recoveries.

  2. Balranald first final product (H2 2026) and progress to steady-state extraction and recovery.

  3. Eneabba construction milestones, Tranche 1 fully drawn by end-2026, and commissioning readiness for mid-2027.

  4. Additional rare earths offtake announcements, including counterparty and pricing terms.

  5. Northern Minerals' Browns Range FID (deadline 30 Sep 2026) and satisfaction of supply-agreement conditions.

  6. SR2/Cataby restart decision and 2027 synthetic rutile contract renewals.

  7. FY2026 results (Feb 2027): further impairments, 2027 guidance and dividend.

  8. The outcome of Rio Tinto's RTIT review and pigment industry rationalisation.

  9. Western rare earth policy (price floors, stockpiling, G7 initiatives) and Chinese export-control changes.

Analyst verdict

Iluka in October 2026 is a company caught between two cycles moving in opposite directions, and the investment debate turns on which one dominates over the next three years.

The legacy mineral sands franchise has endured its worst downturn in a decade. Margins fell from 53% in FY2022 to 9% in H1 2026, FY2025 brought A$566m of write-downs, and the synthetic rutile business has been mothballed. Yet the evidence points to a trough rather than a permanent impairment of the core zircon and rutile business. Pricing is below many competitors' cost curves, capacity is exiting, zircon prices have started to recover, and Iluka has demonstrated it can convert inventory into cash: A$247m of operating cash flow on A$41m of EBITDA in H1 2026. Balranald, once ramped up, materially upgrades the asset base towards higher-value rutile and premium zircon.

The rare earths business is the real value driver, and 2026 has delivered the de-risking that was missing in late 2024:

  • full access to the A$1.65bn government loan;

  • a floor-priced take-or-pay contract with a global automaker;

  • 60% construction completion on budget;

  • a feedstock portfolio spanning the Eneabba stockpile, Balranald, Northern Minerals, Lindian and VHM.

Few non-Chinese assets will offer separated heavy rare earths at scale by 2027–28, and policy momentum favours exactly that capability.

The offsetting risks are leverage, now above A$1.1bn, and the inherent difficulty of commissioning a first-of-kind integrated refinery. The equity therefore behaves like a levered option on Eneabba's successful start-up, underpinned by a recovering but structurally challenged mineral sands base.

Verdict. The risk-reward is constructive for investors with a two-to-three-year horizon and tolerance for execution risk. It warrants a position sized to the binary nature of Eneabba's commissioning. The key evidence to watch is additional floor-priced offtakes, Balranald recoveries and the absence of further capex revisions. Absent those, the stock is likely to remain range-bound and volatile, tracking rare earths sentiment more than mineral sands fundamentals.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenureBackground

Tom O'Leary

Managing Director & CEO

Since 5 Sep 2016 (~10 years)

MD of Wesfarmers Chemicals, Energy & Fertilisers (2010–16); MD of Wesfarmers Energy (2009–10); earlier investment banking (Nikko Principal Investments, Nomura International, London). LLB, BJuris. Age ~62 (Simply Wall St).

Adele Stratton

Chief Financial Officer (reported as CFO and Head of Planning/Development in company materials)

Long-serving CFO

—

Luke Woodgate

General Manager, Investor Relations & Corporate Affairs

—

Named investor and media contact on all 2024–2026 releases

Board of Directors

NameRoleAppointedBackground

James Mactier

Independent Non-Executive Chair; Chair, Nominations & Governance Committee

5 May 2025

24 years at Macquarie, 15 as co-head of Metals & Energy Capital; Chair of Regis Resources; former member of Resource Capital Funds' Managing Partner Advisory Board. Iluka's seventh Chair. Holds 50,000 shares via superannuation.

Tom O'Leary

Managing Director & CEO

Sep 2016

As above

Andrea Sutton

Independent NED; Chair, People & Performance Committee; member, Nominations & Governance

Mar 2021

Former Rio Tinto executive; former CEO of Energy Resources of Australia; boards of ANSTO and NAWO; former NED of Red 5, DDH1 and Infrastructure WA. Acting Chair Dec 2024 – May 2025.

Lynne Saint

Independent NED; Chair, Audit & Risk Committee

Oct 2019

19+ years' leadership at Bechtel Group; BCom, FCPA, FAICD

Susie Corlett

Independent NED

Jun 2019

Mining industry director (details per company website)

—

Independent NED

Jun 2024

Non-executive director of Evolution Mining (per Iluka board page)

Other directors

——

A "Board Changes" announcement was dated March in a recent year (MarketScreener). Full current composition should be confirmed against the 2025 Annual Report.

Major Shareholders

HolderDisclosed position / eventDate

Cooper Investors Pty Ltd

Voting power changed from 7.69% to 6.17%

2025 (TipRanks summary of ASX notice)

State Street Corporation and subsidiaries

Multiple changes in substantial holding

2025–2026

First Sentier Investors (MUFG group)

Became substantial holder

12 Jun 2025

Mitsubishi UFJ Financial Group

Change in substantial holding

2025

UBS Group AG

Ceased to be substantial holder

11 Jul 2025

Index funds (Vanguard, BlackRock, etc.)

Typical ASX 200 index holders; Iluka is held by 31 ASX ETFs, e.g. ~1.9% weight in BetaShares XMET

Aug 2026

Competitive Landscape

Peer Comparison FY2025

CompanyFiscal basisRevenueGrowthMargin indicator

Iluka Resources

FY2025 (Dec)

A$976m mineral sands (A$1,015m statutory)

-13.5%

31% mineral sands EBITDA margin

Tronox Holdings

FY2024 (Dec)

~US$3.1bn (approx., Tronox 10-K)

——

Kenmare Resources

FY2024 (Dec)

~US$0.4bn (approx., Kenmare annual report)

——

Lynas Rare Earths

FY2025 (Jun)

~A$0.56bn (approx., Lynas annual report)

——

Company Snapshot

$841M

Revenue

909

Employees

$2,588.61M

Market Cap

1998

Founded

Perth, Australia

Headquarters

SWOT Analysis

Strengths

  • Strategically unique refinery. Eneabba will be one of very few non-China refineries producing both separated light and heavy rare earth oxides, with design output of ~3,500tpa NdPr and ~170tpa DyTb from the Eneabba stockpile alone (Offtake release, 23 Jun 2026).
  • Low-cost-of-capital funding. The A$1.65bn non-recourse Government loan is fully accessible, with tenor flexible to 2038 (EFA release, 23 Jun 2026; Q4 2025 quarterly).
  • Price-protected first offtake. Take-or-pay with minimum prices, minimum revenue ~US$155m, covering both light and heavy oxides (23 Jun 2026).
  • Exceptional new ore body. Balranald grade exceeds 50% heavy mineral in the production plan and is rich in rutile and premium zircon; both rigs are operational (FY2025 results; H1 2026 results).
  • Liquidity buffer. Inventory valued above A$1bn (FY2025 commentary) enabled A$247m of mineral sands operating cash flow in H1 2026 despite EBITDA of only A$41m.
  • Diversified feedstock pipeline. Northern Minerals (up to 30.5kt REO), Lindian (6ktpa concentrate over 15 years), VHM (86kt REO over 18 years), plus internal Balranald and Wimmera.
  • Australian jurisdiction and safety. All production is in Australia; TRIFR improved to 3.4 in FY2025 from 3.8, then 3.3 in H1 2026.

Weaknesses

  • Collapsing mineral sands profitability. EBITDA margin fell from 53% (FY2022) to 31% (FY2025) and 9% (H1 2026).
  • Statutory losses. FY2025 NPAT was -A$288m after A$566m of impairments and write-downs; H1 2026 NPAT was -A$24m.
  • Leverage. Group net debt rose from A$115m (Dec 2024) to A$1,150m (Jun 2026), with rare earths net debt at A$877m and rising through construction.
  • Customer concentration in titanium feedstocks. The loss of Venator volumes forced SR guidance withdrawal (17 Oct 2025), and SR sales fell 32% in FY2025.
  • High unit costs during transition. 2026 unit cash cost guidance of A$1,585/t versus A$1,054/t in FY2025, reflecting Balranald ramp-up and structurally higher steady-state unit costs.
  • History of capex overruns. Eneabba moved from A$1.2bn (2022 FID) to A$1.7–1.8bn (Dec 2024), with commissioning slipping from 2026 to 2027.
  • Shareholder concern on pay. The remuneration report received only ~82% support at the 2026 AGM.

Opportunities

  • Western rare earth pricing premiums. The US DoD–MP Materials NdPr price floor (July 2025) and G7 coordination point to price mechanisms decoupled from Chinese benchmarks.
  • Additional offtakes. The first contract covers only ~10% of planned 2028–31 production, leaving ~90% to be contracted, potentially at improving terms.
  • Zircon recovery. The Q2 2026 zircon price rose to US$1,546/t with further increases flagged for Q3. Management cites a "recovering zircon market."
  • Pigment supply rationalisation. Closures in Europe and China, tariffs on Chinese pigment, and the Rio Tinto RTIT review could tighten high-grade feedstock markets. SR2 and Cataby can restart "quickly."
  • Wimmera and Typhoon. Long-life zircon and rare earths optionality; the Wimmera flowsheet has been tested successfully.
  • Third-party tolling and refining. A multi-feed refinery designed for decades of operation positions Iluka as a regional processing hub.

Threats

  • Chinese competitive behaviour. Aggressive zircon discounting and low-quality rutile/leucoxene depressed prices in 2025 (Q3 and Q4 2025 quarterlies). Record Chinese rare earth exports in 2025 could cap prices.
  • Pigment demand. Pigment demand depends on US housing and high rates, and pigment industry restructuring may permanently reduce Western chloride capacity.
  • Eneabba execution. The refinery is 60% complete, with commissioning and ramp-up of a complex hydrometallurgical flowsheet still ahead. Rare earth refinery ramp-ups historically take longer than planned.
  • Third-party feed risk. Northern Minerals' supply agreement remains subject to conditions, and its FID timing has slipped repeatedly (targeted no later than 30 Sep 2026). Lindian depends on Malawi.
  • Contract renewal risk. Synthetic rutile contracts renewed in 2023 for four years expire around end-2026/2027, at a time when customers are financially stressed.
  • Currency. Products are priced in US$ and the cost base is in A$, so A$ strength would compress margins. The A$/US$ rate averaged 65c in FY2025.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
19 Feb 2025FY2024 results: mineral sands revenue A$1,129m (-9%), EBITDA A$477m (42% margin), NPAT A$231m (-33%), 8cps dividendContext: start of downturn
15 Apr 2025James Mactier appointed independent NED and Chair, effective 5 May 2025Board renewal after Cole's retirement; shares rose ~3.5–3.8% to ~A$3.56–3.57
5 May 2025Mactier takes office; holds 50,000 sharesGovernance continuity
12 Jun 2025First Sentier Investors (MUFG) becomes substantial holderRegister change
Jul 2025US Government partners with MP Materials on an NdPr price floor (industry event)Iluka cites it as validating non-China pricing structures; supportive for the Eneabba economics narrative
11 Jul 2025UBS Group ceases to be substantial holderRegister change
6 Aug 2025Lindian partnership: US$20m loan and 15-year, 6ktpa monazite offtakeFeedstock diversification; first international feed
Aug 2025H1 2025 results: revenue A$558m (-8%), EBITDA A$218m (39% margin), NPAT A$92m (-31%), capex A$402m, net debt A$164m, interim 2cpsCash outflow phase begins
20 Aug 2025Lindian raises A$91.5m and approves Kangankunde FID, citing the Iluka partnershipDe-risks the Lindian feed
10 Sep 2025Suspension of Cataby (12 months) and SR2 (6 months) from 1 Dec 2025 announcedShares fell ~11% intraday to ~A$5.76; cost and cash preservation
Sep 2025Northern Minerals Browns Range DFS (~8% of global Dy/Tb supply; first production targeted 2028)Supports the Iluka xenotime feed thesis
Oct 2025China expands rare earth export controls (industry); Iluka shares reach a 2025 high of A$9.48Rare earths re-rating of Iluka
17 Oct 2025Q3 2025 quarterly; synthetic rutile sales guidance withdrawn after loss of Venator volumesTitanium feedstock revenue risk materialised
27 Oct 2025Northern Minerals A$60.5m placement; FID targetedFeed partner progress
Q4 2025Cost review: ~120 roles rationalised, ~A$36m 2026 savingsCost base reset
1 Dec 2025Cataby and SR2 idledSR production guidance for 2026 is nil
Dec 2025Balranald commissioning commencesProject milestone
Jan 2026Balranald mining commences; first rig at target extraction ratesUGM technology validated at commercial scale
29 Jan 2026Q4 2025 quarterly: record ZIC; FY2025 Z/R/SR production 559kt; unit cost A$1,054/t; Eneabba spend A$865m; 2026 guidance issuedGuidance reset to 265kt
18 Feb 2026FY2025 results: revenue A$976m (-13.5%), EBITDA A$300m (31% margin), NPAT -A$288m after A$566m adjustments; group net debt A$1,057m; FY dividend 5cpsFirst statutory loss; balance sheet transition
30 Mar 20262025 final dividend of 3cps paid—
30 Apr 202671st AGM (Perth); remuneration report ~82% support; market cap ~A$3.5bnElevated protest vote, short of a strike
Apr 2026Q1 2026 quarterly: lower production and revenue, stable zircon prices, project ramp-upsWeak trough quarter
23 Jun 2026First rare earths offtake: global automaker, take-or-pay, 1,200t REO, 2028–31, minimum revenue ~US$155mKey commercial de-risking
23 Jun 2026EFA confirms access to the full A$1.65bn loan; Civmec awarded SMPEI contract; refinery >50% completeFunding fully unlocked
2 Jul 2026VHM Goschen supply agreement: 86kt REO over 18 yearsLong-term feed security
28 Jul 2026Q2 2026 quarterly: sales 157kt, zircon price up to US$1,546/t; H1 NPAT guided at ~-A$25mShares rose ~16% to ~A$6.76
19 Aug 2026H1 2026 results: revenue A$433m (-22%), mineral sands EBITDA A$41m (-81%), NPAT -A$24m, mineral sands OCF A$247m, mineral sands net debt A$273m, interim 3cpsCash-flow inflection despite earnings trough; shares fell ~1.5% on the day
24 Sep 20262026 interim dividend of 3cps paid (record date 1 Sep 2026)—
30 Sep 2026Northern Minerals' stated deadline for Browns Range FID–
16 Oct 2026 (scheduled)Q3 2026 quarterly reviewNext catalyst

Product Offering

  • Iluka Resources
    • Rare Earth Metals

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

5 charts
Revenue by Segment: Z/R/SR revenue fell from AUD 1,043 Mn in FY2024 to AUD 908 Mn in FY2025.
Iluka Resources — Revenue by Segment
Series (AUD Mn)FY2024FY2025
Z/R/SR revenue1,043908
Ilmenite and other revenue8567
Mineral sands revenue1,128976

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.